EUROPE VISCOSUPPLEMENTATION MARKET ANALYSIS

Market Challenges And Opportunities

Europe Viscosupplementation Market– Driver

Increasing prevalence of osteoarthritis

Increasing prevalence of osteoarthritis is expected to propel the growth of the Europe viscosupplementation market over the forecast period. For instance, according to an article published in the National Library of Medicine Journal in September 2022, reported the age-standardized point prevalence and annual incidence rates of rheumatoid arthritis were 446.6 and 24.9 in 2021, which increased by 12.4% and 9.9% from 2001, respectively.

Increasing geriatric population

Increasing geriatric population is expected to aid in the growth of the market during the forecast period. As with advancing age the incidence of various auto-immune conditions, such as rheumatoid arthritis, increases which results in a rise in testing volumes translating to higher demand for testing techniques for rheumatoid arthritis. As rheumatoid arthritis is mostly common among old people, and the geriatric population has been increasing recently, the opportunities in the Europe viscosupplementation market are expected to be on the rise in the future. For instance, according to an article published in the World Health Organization in October 2022, reported 1 in 6 people in the world will be aged 60 years or over in 2030. the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Europe Viscosupplementation Market: Restraint

Side-Effects of Viscosupplementation

The wide range of viscosupplementation are used by professionals for performing osteoarthritis procedures on various patients of different age groups. The products are used for joint replacement, hip arthroscopy, and shoulder arthroscopy, among more. As viscosupplementation benefits the patients by maintaining their range of motion, flexibility, and movement, there are various health complications associated with it. Thus, side effects and complications associated with the use of viscosupplementation are hampering the demand for viscosupplementation in the market. For instance, in July 2021, according to an article published in the National Library of Medicine Journal reported, risks associated with hyaluronan are mild and similar to those of other viscosupplements, including allergies, injection site pain and inflammation, infection, and potential temporary arthritic flares. Other rare side effects include itching, numbness/tingling, headache, dizziness, and back pain